The expressions of FoxA2 and FoxA3 in cholangiocarcinoma were at similar levels with those in colon adenocarcinoma, liver hepatocellular carcinoma, pancreatic adenocarcinoma, rectum adenocarcinoma, and stomach adenocarcinoma (Figure S1B,C). The gene discussed is FOXA2; the disease is gastric adenocarcinoma.